Fresenius Kabi Oncology Ltd Annually Results

Gross Sales

530.78

490.26

318.41

278.25

326.73

Excise Duty

13.36

11.02

11.14

9.42

13.65

Net Sales

517.4

479.23

307.26

268.82

313.07

Other Operating Income

8.98

9.27

4.98

13.77

0

Other Income

3.74

14.43

17.2

125.36

12.73

Total Income

530.14

502.94

329.45

407.97

325.82

Total Expenditure

428.57

466.3

415.32

268.25

286.63

PBIDT

101.56

36.63

-85.87

139.72

39.18

Interest

31.79

32.18

29.12

15.18

7.53

PBDT

69.76

4.44

-115

124.54

31.65

Depreciation

33

31.94

28.23

18.97

7.26

Minority Interest Before NP

0

0

0

0

0

Tax

14

12.8

1.12

6.59

3.25

Deferred Tax

6.76

-6.92

1.65

-0.28

0.44

Reported Profit After Tax

16.01

-33.36

-146.02

98.58

19.73

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

16.01

-33.36

-146.02

98.58

19.73

Extra-ordinary Items

-0.56

5.69

-11.69

118.75

0

Adjusted Profit After Extra-ordinary item

16.58

-39.06

-134.32

-20.16

19.73

EPS (Unit Curr.)

1

0

0

6.28

1.27

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

15.81

15.81

15.81

15.67

15.67

Public Shareholding (Number)

1,58,22,766

1,58,22,766

1,58,22,766

0

4,92,92,656

Public Shareholding (%)

10

10

10

0

31.45

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

14,24,04,896

14,24,04,896

14,24,04,896

10,22,99,848

0

Non Encumbered - % in Total Promoters Holding

100

100

100

100

0

Non Encumbered - % in Total Equity

90

90

90

65.3

0

PBIDTM(%)

19.63

7.64

-27.95

51.97

12.51

PBDTM(%)

13.48

0.92

-37.42

46.32

10.11

PATM(%)

3.09

-6.96

-47.52

36.67

6.3